Cargando…
Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365573/ https://www.ncbi.nlm.nih.gov/pubmed/30725243 http://dx.doi.org/10.1186/s40169-019-0222-0 |
_version_ | 1783393450090037248 |
---|---|
author | Polansky, Hanan Itzkovitz, Edan Javaherian, Adrian |
author_facet | Polansky, Hanan Itzkovitz, Edan Javaherian, Adrian |
author_sort | Polansky, Hanan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6365573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-63655732019-02-27 Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases Polansky, Hanan Itzkovitz, Edan Javaherian, Adrian Clin Transl Med Correction Springer Berlin Heidelberg 2019-02-06 /pmc/articles/PMC6365573/ /pubmed/30725243 http://dx.doi.org/10.1186/s40169-019-0222-0 Text en © Springer-Verlag GmbH Germany, Part of Springer Nature 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Correction Polansky, Hanan Itzkovitz, Edan Javaherian, Adrian Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases |
title | Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases |
title_full | Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases |
title_fullStr | Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases |
title_full_unstemmed | Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases |
title_short | Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases |
title_sort | expression of concern to: clinical study of gene-eden-vir/novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365573/ https://www.ncbi.nlm.nih.gov/pubmed/30725243 http://dx.doi.org/10.1186/s40169-019-0222-0 |
work_keys_str_mv | AT polanskyhanan expressionofconcerntoclinicalstudyofgeneedenvirnoviriningenitalherpessuppressivetreatmentsafelydecreasesthedurationofoutbreaksinbothsevereandmildcases AT itzkovitzedan expressionofconcerntoclinicalstudyofgeneedenvirnoviriningenitalherpessuppressivetreatmentsafelydecreasesthedurationofoutbreaksinbothsevereandmildcases AT javaherianadrian expressionofconcerntoclinicalstudyofgeneedenvirnoviriningenitalherpessuppressivetreatmentsafelydecreasesthedurationofoutbreaksinbothsevereandmildcases |